In the Globe and Mail today! In a separate note, Ms. Stellick cut her target for shares of Quipt Home Medical Corp. (QIPT-X +0.15%increase ) to $13.25 from $13.40 with a “buy” rating following the acquisition of a strategic location in Central Illinois.
“QIPT continues to expand through M&A to build out a national DME platform, completing six acquisitions totalling more than $16-million in revenues since July,” she said. “The acquisition announced [Tuesday] expands the Company’s footprint within Illinois, a market with higher-than-average COPD prevalence in the U.S.. With $30-million cash on hand, access to
$20-million of credit, and an active pipeline, we expect more strategic M&A in the next six months. These results confirm that QIPT continues to successfully execute on its growth strategy and benefit from increased scale through operational leverage.”
G
halted
M
The bottom was in should advance through December
M
Heating up
C
400 @ $6.76 CAD, no brainer
K
In the Globe and Mail today. * IA Capital Markets analyst Chelsea Stellick raised her Quipt Home Medical Corp. (QIPT-X) target to $13.50 from $13.25, topping the $12.16 average, with a “buy” rating.
“QIPT continues to expand through M&A to build out a national DME platform, and recent momentum is in line with management’s commentary and our call for a larger acquisition by year end. These three acquisitions unambiguously create value and reinforce the value creation that make QIPT our top pick,” she said.
M
this could be interesting 👍
K
$200 million seems like a lot...
M
I wonder what’s happening
d
$QIPT.V is moving but in the wrong direction. Technicals are good even it's moving downwards.. anyone know what is going with this company?
M
Earnings coming in mid November
T
still needs to go lower before I get back into this stock. Maybe around $5.50 I'll start thinking harder about risking my money again.
G
Participating in the LD Micro Main Event conference October 12 at 9:30 ET. Investors should sign in and listen!
M
Finished on the upside finally. It should capitulated into an upward trajectory.
N
i reached out to the management at quipt regarding the stock performance since moving to NASDAQ. Here's what they said>>
"Hi Naveed,
Thank you for the note,
We are extremely excited to have completed our NASDAQ listing, a major milestone for the company. We continue to work diligently on growing our business both organically and inorganically, and we just showcased record Q2 results.
At times, the market doesn’t reflect the underlying fundamentals, and it seems to be one of those periods, with weakness stemming from some of our peers.
We will continue to work hard to execute on our strategic vision, and feel we are in a fantastic position to have a very busy 2nd half of the year on the M&A front.
Thank you again,"
K
Fantastic numbers. One to continue watching and buying.
P
Amazing results! Keep up the good work...Nasdaq here we come!
https://chart-analysis.tools/Bullish-Charts
In a separate note, Ms. Stellick cut her target for shares of Quipt Home Medical Corp. (QIPT-X +0.15%increase
) to $13.25 from $13.40 with a “buy” rating following the acquisition of a strategic location in Central Illinois.
“QIPT continues to expand through M&A to build out a national DME platform, completing six acquisitions totalling more than $16-million in revenues since July,” she said. “The acquisition announced [Tuesday] expands the Company’s footprint within Illinois, a market with higher-than-average COPD prevalence in the U.S.. With $30-million cash on hand, access to
$20-million of credit, and an active pipeline, we expect more strategic M&A in the next six months. These results confirm that QIPT continues to successfully execute on its growth strategy and benefit from increased scale through operational leverage.”
* IA Capital Markets analyst Chelsea Stellick raised her Quipt Home Medical Corp. (QIPT-X) target to $13.50 from $13.25, topping the $12.16 average, with a “buy” rating.
“QIPT continues to expand through M&A to build out a national DME platform, and recent momentum is in line with management’s commentary and our call for a larger acquisition by year end. These three acquisitions unambiguously create value and reinforce the value creation that make QIPT our top pick,” she said.
"Hi Naveed,
Thank you for the note,
We are extremely excited to have completed our NASDAQ listing, a major milestone for the company. We continue to work diligently on growing our business both organically and inorganically, and we just showcased record Q2 results.
At times, the market doesn’t reflect the underlying fundamentals, and it seems to be one of those periods, with weakness stemming from some of our peers.
We will continue to work hard to execute on our strategic vision, and feel we are in a fantastic position to have a very busy 2nd half of the year on the M&A front.
Thank you again,"